at Guided Therapeutics
Chief Executive Officer.
Cartwright was appointed CEO in January 2014. He brings
over 30 years of experience working in the In vitro
diagnostics industry. He joins Guided Therapeutics from
Omnyx, LLC, a Joint Venture between GE Healthcare and
University of Pittsburgh Medical Center, where, as CEO
for over four years he founded and managed the
successful development of products for the field of
Digital Pathology. Prior to his work with Omnyx, LLC, he
was President of Molecular Diagnostics for GE
Before joining GE, he
was Divisional Vice President/General Manager for Abbott
Diagnostics’ Molecular Diagnostics business. In his 24
year career at Abbott, he also served as Divisional Vice
President for U.S. Marketing for five years.He received
a Masters of Management degree from Northwestern’s
Kellogg School of Management and also holds a Ph.D. in
chemistry from Stanford University and an AB from
L. Faupel, Ph.D., Chief Scientific Officer.
Faupel has more than 25 years of experience as a senior
executive developing non-invasive alternatives to
surgical biopsies and blood tests, especially in the
area of cancer screening and diagnostics. Prior to
coming to SpectRx in 1998 as Vice President of Business
Development and then co-founding Guided Therapeutics,
Dr. Faupel was a senior executive and co-founder of
is the inventor on 20 U.S. patents and author of
numerous scientific publications and presentations,
appearing in such peer-reviewed journals as The Lancet,
Cancer, The European Journal of Radiology and Diabetes
Technology & Therapeutics. He has served as a member of
the European School of Oncology Task Force and on
National Institutes of Health review panels. Dr. Faupel
earned his Ph.D. in neuroanatomy and physiology from the
University of Georgia.
L. Fowler, Sr. Vice-president, Engineering.
Mr. Fowler is responsible for identifying new
technical and business opportunities for Guided Therapeutics. These opportunities include
new technologies, product lines or business acquisitions that are strategic to
the Company's business. Mr. Fowler was formerly VP of Engineering at Guided
where he oversaw the successful development of the BiliChek® Non-invasive Bilirubin Analyzer.
Mr. Fowler has more than 20 years experience in developing and bringing to
market electro-optical devices. Prior to joining Guided Therapeutics, Mr. Fowler was
President of Laser Atlanta Optics, Inc. where he developed and launched a new,
low-cost laser range finder. He has also held management positions with GEC
Avionics, Inc. and General Dynamics. Mr. Fowler holds a degree in Electrical
Engineering from the University of Texas.